NEIMETH INTERNATIONAL PHARMACEUTICAL PLC
NEIMETH INTERNATIONAL PHARMACEUTICAL PLC operates in various business sectors.
Market Cap & Net Worth: NEIMETH INTERNATIONAL PHARMACEUTICAL PLC (NEIMETH)
NEIMETH INTERNATIONAL PHARMACEUTICAL PLC (XNSA:NEIMETH) has a market capitalization of $61.26 (₦94.52K) as of March 18, 2026. Listed on the XNSA stock exchange, this Nigeria-based company holds position #50317 globally and #88 in its home market, demonstrating a -0.48% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NEIMETH INTERNATIONAL PHARMACEUTICAL PLC's stock price ₦10.35 by its total outstanding shares 9132 (9.13K).
NEIMETH INTERNATIONAL PHARMACEUTICAL PLC Market Cap History: 2015 to 2026
NEIMETH INTERNATIONAL PHARMACEUTICAL PLC's market capitalization history from 2015 to 2026. Data shows growth from $4.35 to $61.26 (27.10% CAGR).
NEIMETH INTERNATIONAL PHARMACEUTICAL PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NEIMETH INTERNATIONAL PHARMACEUTICAL PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of NEIMETH by Market Capitalization
Companies near NEIMETH INTERNATIONAL PHARMACEUTICAL PLC in the global market cap rankings as of March 18, 2026.
Key companies related to NEIMETH INTERNATIONAL PHARMACEUTICAL PLC by market ranking:
- CTS Global Equity Group Inc. (PSE:CTS): Ranked #50308 globally with a market cap of $61.40 USD ( ₱3.60K PHP).
- Calculus VCT plc (LSE:CLC): Ranked #50309 globally with a market cap of $61.30 USD ( GBX503.85K GBX).
- FIRST CLASS MET. LS-001 (F:WN9): Ranked #50318 globally with a market cap of $60.24 USD ( €58.69 EUR).
- FIRST MUTUAL HOLDINGS LIMITED (XZIM:FML): Ranked #50319 globally with a market cap of $60.21 USD ( ZWL3.93 Million ZWL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #50308 | CTS Global Equity Group Inc. | PSE:CTS | $61.40 | ₱0.40 |
| #50309 | Calculus VCT plc | LSE:CLC | $61.30 | GBX53.25 |
| #50318 | FIRST CLASS MET. LS-001 | F:WN9 | $60.24 | €0.01 |
| #50319 | FIRST MUTUAL HOLDINGS LIMITED | XZIM:FML | $60.21 | ZWL417.97 |
NEIMETH INTERNATIONAL PHARMACEUTICAL PLC Historical Marketcap From 2015 to 2026
Between 2015 and today, NEIMETH INTERNATIONAL PHARMACEUTICAL PLC's market cap moved from $4.35 to $ 61.26, with a yearly change of 27.10%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₦61.26 | +78.45% |
| 2025 | ₦34.33 | +153.28% |
| 2024 | ₦13.55 | +18.04% |
| 2023 | ₦11.48 | +35.66% |
| 2022 | ₦8.46 | -18.29% |
| 2021 | ₦10.36 | -21.52% |
| 2020 | ₦13.20 | +259.68% |
| 2019 | ₦3.67 | -12.57% |
| 2018 | ₦4.20 | +4.00% |
| 2017 | ₦4.04 | +5.77% |
| 2016 | ₦3.82 | -12.36% |
| 2015 | ₦4.35 | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of NEIMETH INTERNATIONAL PHARMACEUTICAL PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $61.26 USD |
| MoneyControl | $61.26 USD |
| MarketWatch | $61.26 USD |
| marketcap.company | $61.26 USD |
| Reuters | $61.26 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.